Comment
. 1991 Nov;14(11):483-4; author reply 485-6.
doi: 10.1016/0166-2236(91)90057-2.
Cholinergic controversies
- PMID: 1726763
- DOI: 10.1016/0166-2236(91)90057-2
Item in Clipboard
Comment
Cholinergic controversies
Trends Neurosci.
1991 Nov.
No abstract available
Comment on
-
Cholinergic mechanisms in learning, memory and dementia: a review of recent evidence.Trends Neurosci. 1991 Jun;14(6):220-3. doi: 10.1016/0166-2236(91)90117-d. Trends Neurosci. 1991. PMID: 1716012 Review.
Similar articles
-
The current status of the cortical cholinergic system in Alzheimer's disease and Parkinson's disease.Prog Brain Res. 1986;70:105-32. doi: 10.1016/s0079-6123(08)64300-9. Prog Brain Res. 1986. PMID: 3554348 Review. No abstract available.
-
The cholinergic hypothesis: a historical overview, current perspective, and future directions.Ann N Y Acad Sci. 1985;444:332-58. doi: 10.1111/j.1749-6632.1985.tb37600.x. Ann N Y Acad Sci. 1985. PMID: 2990293 No abstract available.
-
Behavioral aspects of cholinergic transmission: role of basal forebrain cholinergic system in learning and memory.Prog Brain Res. 1993;98:405-11. doi: 10.1016/s0079-6123(08)62424-3. Prog Brain Res. 1993. PMID: 8248528 Review. No abstract available.
-
Dementia of Parkinson's disease and Alzheimer's disease. Is there a difference?J Am Geriatr Soc. 1986 Jun;34(6):475-8. doi: 10.1111/j.1532-5415.1986.tb03416.x. J Am Geriatr Soc. 1986. PMID: 3700936 No abstract available.
-
Neurotransmitters and CNS disease. Dementia.Lancet. 1982 Nov 27;2(8309):1200-4. doi: 10.1016/s0140-6736(82)91212-0. Lancet. 1982. PMID: 6128503 No abstract available.
Cited by
-
Phenserine: a physostigmine derivative that is a long-acting inhibitor of cholinesterase and demonstrates a wide dose range for attenuating a scopolamine-induced learning impairment of rats in a 14-unit T-maze.Psychopharmacology (Berl). 1993;112(4):415-20. doi: 10.1007/BF02244888. Psychopharmacology (Berl). 1993. PMID: 7871051
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
